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ABSTRACT 
Background: Myocarditis is associated with high morbidity and mortality in 
childhood, but the pathogenesis  of this disease is still unclear. Current knowl- 
edge indicates that complex immunopathogenic  mechan isms are involved. It is 
understood that leukotrienes play an important  role in the inflammation asso- 
ciated with asthma, and recent reports  indicate that leukotrienes part ic ipate in 
immune processes  and in autoimmunity. 
Objective: The aim of this study was to assess the role of leukotriene synthesis 
in the development of myocardial inflammation and necrosis during myocarditis. 
Methods: The effect of zileuton, a leukotriene synthesis inhibitor, was as- 
sessed in an experimental  model of auto immune myocardit is in rats. Healthy 
adult (10-week-old) male Wistar albino rats were randomly divided into 3 groups. 
Groups A and B received injections of 1.0 mg porcine cardiac myosin to induce 
auto immune myocardit is  and group C (the control group) received phosphate-  
buffered saline. Group B also received zileuton by oral gavage at 100 mg/kg • d -1. 
Myocardial inf lammation was assessed biochemical ly via serum concentrat ions 
of creatine kinase MB subunit  (CK-MB) and troponin T. Cardiac t issue was 
assessed macroscop ica l ly  (0 = no inf lammation; 1 = a small d iscolored focus; 
2 = diffuse d isco lored areas cover ing less than half of the cardiac surface; 
3 = diffuse discolored areas covering more than half of the cardiac surface) and 
microscopical ly (0 = no inflammation; 1 = <5% infiltration; 2 = 5% to <10% infil- 
tration; 3 = 10% to < 20% infiltration; 4 = >20% infiltration). 
Results: Twenty-four ats were divided equally into 3 groups. All rats sur- 
vived the duration of the study. After 21 days, all rats were euthanized. No sig- 
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nificant differences were found between groups A and B in terms of serum con- 
centrations of CK-MB or troponin T. The microscopic pathology score was sig- 
nificantly lower in group B (myosin + zileuton) than in group A (myosin only) 
(0.12 [0.35] vs 1.25 [1.03]; P = 0.023). The microscopic pathology score was sig- 
nificantly higher in group A than in group C (1.25 [1.03] vs 0; P< 0.01), but the 
difference between groups B and C was not statistically significant. The macro- 
scopic pathology score was significantly higher in group A than in group B 
(1.37 [0.91] vs 0.37 [0.51]; P = 0.029). The macroscopic pathology score was signifi- 
cantly higher in group A than in group C (1.37 [0.91] vs 0; P< 0.01). There was no sig- 
nificant difference in macroscopic scores between groups B and C (0.37 [0.51] vs 0). 
Conclusions: In this study of the effects of zileuton in an experimental rat 
model of autoimmune myocarditis, no significant differences were found in the 
serum concentrat ions of the biochemical markers in the 2 groups administered 
myosin. However, lower macroscopic and microscopic inflammation scores in 
the zileuton-treated group (group B) compared with the group administered only 
myosin (group A) suggest hat zileuton, a leukotriene-synthesis inhibitor, may 
suppress the development of experimental autoimmune myocarditis in rats. 
(Curt Ther Res Clin Exp. 2007;68:262-270) Copyright © 2007 Excerpta Medica, Inc. 
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INTRODUCTION 
Myocarditis is associated with high morbidity and mortal ity in children. 1The 
pathogenesis of myocardit is is not yet clear. Although immunoresponse and 
autoimmunity appear to be important in the pathogenesis of myocarditis, 
regardless of the original etiology, the mechanisms involved in the development 
of inf lammatory processes remain to be clarified. 2
Cardiac myosin-induced autoimmune myocardit is in rats was first defined by 
Kodama et al, 3 who found that the development of giant cell myocardit is in rats 
was similar to that of myocardit is in humans. Since then, this model has also 
been used to clarify the immunopathogenic mechanisms of human myocardi- 
tis. 4 A variety of autoantigens (eg, cardiac c¢ and [8 myosins, [8-adrenergic recep- 
tors, and mitochondrial  membrane and extracellular matrix proteins) are tar- 
gets for autoimmune responses. 5 Antigen-presenting cells (APCs), which are 
located on the myocardium, are complexed with myosin. Autoantigens are pre- 
sented to the immune system by the APCs. Although both autoimmune T cells 
and autoantibodies play a role in myosin-induced autoimmunity, T cells are the 
main immune responder cells. 5 Investigators have shown that both CD 4 and CD 8 
T cells are involved in autoimmune myocarditis. Activation of the immune sys- 
tem results in inflammation and necrosis of myocardial cells. 
Leukotrienes, which are products of membrane phospholipids, are known 
to be potent bronchoconstr ictors  and inf lammatory mediators of asthma. 6 
However, recent studies suggest a relationship between leukotrienes and other 
immune responses. Leukotrienes have proinf lammatory effects and are thought 
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to play an important role in the development of immune responses and in 
autoimmunity. 6,7Despite these recent studies, the role of leukotrienes in the 
pathogenesis of myocarditis has not been addressed in the literature 
The purpose of this study was to assess the role of leukotriene synthesis in 
the pathogenesis of myocarditis. 
MATERIALS AND METHODS 
Healthy, adult (10-week-old), male Wistar albino rats were randomly divided 
into 3 groups. Groups A and B were immunized twice SQ (on days 0 and 7) with 
porcine cardiac myosin 1.0 mg (Sigma M0531, Sigma-Aldrich, St. Louis, 
Missouri) in an equal volume of Freund's complete adjuvant (Sigma F5881, 
Sigma-Aldrich) containing 11.0 mg/mL of heat-killed Mycobacterium tuberculosis 
R37a. The total volume injected on both occasions was 0.2 mL. The control 
group (group C) was injected with phosphate-buffered saline. At the beginning 
of the study, 2 mL of venous blood was withdrawn via venous puncture from the 
tail dorsal vein of each rat. The weight of the rats was also recorded at this time. 
The animals in this study were treated according to the previously published 
guidelines. 8 The ethics committee of the Faculty of Medicine, Fatih University, 
Ankara, Turkey, approved the study. 
Of the 2 groups immunized with myosin, group B was also given zileuton 
([_+]-l-[1-benzo(b)thien-2-ylethyl]-l-hydroxyurea), a potent inhibitor of 
5-1ipoxygenase. Zileuton (Zyflo ®, Abbott Laboratories, Abbott Park, Illinois) was 
prepared by grinding the tablet into powder and suspending it in water at 
50 mg/mL. The drug was administered by oral gavage at 100 mg/kg/d starting 
on day 0 and continuing until day 21. 
On day 21, all animals were euthanized under intramuscular ketamine anes- 
thesia (0.5 mg/kg). Anterior thoracotomy was performed and macroscopic car- 
diac findings were assessed. Blood samples were taken from the inferior vena 
cava. Heart and body weight were recorded for all rats. 
Macroscopic findings were classified into 4 grades as previously described9: 
0 = no inflammation; 1 = a small discolored focus; 2 = diffuse discolored areas 
covering less than half of the cardiac surface; and 3 = diffuse discolored areas 
covering more than half of the cardiac surface. 
The hearts were excised, fixed in 10% buffered formalin, and embedded in 
paraffin. Transverse sections of the heart specimens were prepared, stained with 
hematoxylin and eosin, and examined by light microscopy for evidence of 
mononuclear nd polynuclear cellular infiltration and necrosis. Microscopic find- 
ings of myocardial damage and cellular infiltration were graded on the following 
scale: 0 = no inflammation; 1 = _<5% infiltration; 2= 5% to <10% infiltration; 3= 10% 
to <20% infiltration; and 4 = _>20% infiltration. All pathology investigations and 
scoring were done by 2 pathologists who were blinded to the treatment group. 
The serum concentrations of the cardiac isoenzyme of creatine kinase MB 
subunit (CK-MB) and troponin T were measured to determine myocardial damage. 
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Serum concentrations of CK-MB were measured using immunoinhibition assay 
by automated clinical chemistry analyzer (Hitachi 912, Roche Diagnostics GmbH, 
Mannheim, Germany). Serum troponin T concentration was obtained using a third- 
generation assay (Elecsys ® 2010 Analyzer, Roche Diagnostics GmbH). The assay 
kits of CK-MB and serum troponin T were obtained from the same company. 
Macroscopic and microscopic scores, the ratio of heart weight o body weight, 
and biochemical findings (CK-MB and troponin T) of the 3 groups were compared. 
Statistical Analysis 
Data were analyzed using SPSS for Windows (SPSS Inc., Chicago, Illinois). 
Because all groups had a nonhomogeneous distribution, the nonparametric 
Mann-Whitney Utest was used to compare between-group data. Results are pre- 
sented as mean (SD). P ~ 0.05 was considered statistically significant. A sample 
size power analysis was not done. 
RESULTS 
Twenty-four rats were divided equally into 2 groups. All rats survived up to the 
time they were euthanized (day 21). None of the rats had significant changes in 
body weight from baseline to the end of the study. 
No statistically significant differences were found among the 3 groups with 
regard to heart weight or the ratio of heart weight to body weight (Table). 
Serum concentrations of CK-MB and troponin T were not significantly differ- 
ent between group A (myosin) and group B (myosin + zileuton). Similarly, there 
were no significant differences between the active study drug groups and group C 
(control group). 
Microscopic evaluation showed mild to moderate inflammation i  6 rats in 
group A and mild inflammation i  3 rats in group B (Figure). Focal infiltration 
by inflammatory cells was detected and necrosis was limited to cardiac 
myocytes. The mean (SD) microscopic pathology score was significantly lower 
in group B than in group A (0.12 [0.35] vs 1.25 [1.03]; P = 0.023) (Table). The 
score of group A was also significantly higher than in group C (1.25 [1.03] vs 0; 
P < 0.01); however, there was no statistically significant difference between 
group B and group C. 
The mean (SD) macroscopic pathology score was significantly higher for 
group A than that of group B (1.37 [0.91] vs 0.37 [0.51]; P = 0.029) (Table). The 
score of group A was also significantly higher than that of group C (1.37 [0.91] 
vs 0; P < 0.01). There was no significant difference in macroscopic scores 
between groups B and C (0.37 [0.51] vs 0). 
DISCUSSION 
Immunologic mechanisms (eg, immunoresponse against viral agents, autoim- 
munity) are important factors in the pathogenesis of myocarditis. 2,1° Humoral 
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Figure. Cardiac tissue slides from an experimental autoimmune myocarditis rat 
model. (A) Focal myocarditis and myocardial necrosis observed in a rat 
administered porcine cardiac myosin only (group A) (hematoxylin and eosin; 
original magnification X400). (B) Zileuton-treated group (group B) shows no 
marked inflammatory infiltrate (hematoxylin and eosin; original magnifica- 
tion X400). 
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and cellular immunity and many kinds of inflammatory mediators participate in
the development of inflammation and necrosis in myocarditis. 11 In viral 
myocarditis, the direct cytopathic effects of the infecting microorganism are fol- 
lowed by the immune system's attempt o clear the virus from body. Natural 
killer and cytotoxic T cells attack infected cells, which may lead to myocyte 
inflammation and necrosis. 12 Heart-specific autoantibodies can also contribute 
to myocyte damage. 13 
Leukotrienes participate in several stages of the innate immunoresponse and 
in autoimmunity. 14 It is understood that leukotrienes act as important media- 
tors in the inflammation of asthma, but there is limited knowledge about the 
role they play in the pathogenesis of other inflammatory diseases. To the best 
of our knowledge, the present study is the first to suggest hat the leukotriene- 
synthesis inhibitor zileuton suppressed myocardial inflammation and necrosis 
in rats. This finding supports the possibility that leukotrienes play a role in the 
development of myocardial inflammation and necrosis in myocarditis. However, 
the mechanism of this effect is still a question for further esearch, as is the pos- 
sibility of using zileuton in the treatment of myocarditis. 
We can suggest some hypotheses to explain the mechanism by which inhi- 
bition of leukotriene synthesis might suppress myocardial inflammation. 
Leukotrienes might support the function of the dendritic cells that present 
cardiac autoantigens to cytotoxic T cells. 15 A decreased leukotriene level 
might inhibit this process and thereby prevent he initiation of the autoim- 
mune response. Another possibility is that leukotrienes support  the migra- 
tion of neutrophils and cytotoxic T cells to the area of inflammation and that 
inhibition of leukotriene synthesis can inhibit this migration. 16 They also 
increase the autoant ibody product ion mediated by proinf lammatory 
cytokines, including tumor-necrosis factor-or and interleukin 8.16 Decreased 
leukotriene levels may lead to less cytokine production and result in milder 
inflammation. 
Our biochemical results did not show any correlation with pathologic speci- 
mens. This might be explained by the low specificity and sensitivity of CK-MB 
and troponin T in the diagnosis of myocarditis. 2,17 
Limitations 
The blood samples withdrawn from the tail dorsal vein of the rats were not 
large enough to allow for the measurement of leukotriene l vel. However, in our 
opinion the inhibitory effect of zileuton on leukotriene synthesis and the less 
severe myocarditis in the zileuton-treated rats, which was demonstrated histo- 
logically, are important findings. In addition, showing autoimmune antibodies 
and T cells in myocardial tissue by immunohistochemical st ining may be more 
definitive than hematoxylin and eosin staining for autoimmune myocarditis. 
This was an experimental study to investigate whether leukotrienes have a 
role in the pathogenesis of autoimmune myocarditis. Further clinical studies 
are needed to clarify the effectiveness of zileuton therapy in humans. The clini- 
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cal effects of zileuton should especially be studied after myocardit is has devel- 
oped, rather than prior to the development of any pathologic hanges, as in this 
study. 
CONCLUSIONS 
In this study of the effects of zileuton in an experimental rat model of autoim- 
mune myocarditis, no significant differences were found in the serum concen- 
trations of the biochemical markers in the 2 active groups (A and B). However, 
lower macroscopic and microscopic inflammation scores in the zileuton-treated 
group (group B) compared with the group administered only myosin suggests 
that zileuton, a leukotriene-synthesis inhibitor, may suppress the development 
of experimental utoimmune myocardit is in rats. 
REFERENCES 
1. Doolan A, Langlois N, Semsarian C. Causes of sudden cardiac death in young 
Australians. Med J Aust. 2004; 180:110-112. 
2. Magnani JW, Dec GW. Myocarditis: Current trends in diagnosis and treatment. 
Circulation. 2006;113:876-890. 
3. Kodama M, Matsumoto Y, Fujiwara M, et al. A novel experimental model of giant cell 
myocarditis induced in rats by immunization with cardiac myosin fraction. Clin 
Immunol Immunopathol. 1990;57:250-262. 
4. Shioji K, Kishimoto C, Nakayama Y, Sasayama S.Strain difference in rats with experi- 
mental giant cell myocarditis. Jpn Circ J. 2000;64:283-286. 
5. Huber SA. Autoimmunity in myocarditis: Relevance of animal models. Clin Immunol 
Immunopathol. 1997;83:93-102. 
6. Hedqvist P, Gautam N, Lindbom L. Interactions between leukotrienes and other 
inflammatory mediators/modulators in the microvasculature. Am J Respir Crit Care 
Med. 2000; 161:S 117-$119. 
7. Sharma JN, Mohammed LA. The role of leukotrienes in the pathophysiology of 
inflammatory disorders: Is there a case for revisiting leukotrienes as therapeutic tar- 
gets? Inflammopharmacology. 2006; 14:10-16. 
8. Association for Assessment and Accreditation of International Laboratory Animal 
Care. In: Institute of Laboratory Animals Resources, Commission on Life Sciences, 
National Research Council. Guide for the Care and Use of Laboratory Animals. 
Washington, DC: National Academy Press; 1996. 
9. Milenkovic M, Vucicevic D, Milosavljevic P, et al. Suppression of experimental uto- 
immune myocarditis by sodium fusidate (fusidin). Pharmacol Res. 2005;52:491-496. 
10. Burian J, Buser P, Eriksson U. Myocarditis: The immunologist's view on pathogene- 
sis and treatment. Swiss Med Wkly. 2005;135:359-364. 
11. Ayach B, Fuse K, Martino T, Liu P. Dissecting mechanisms of innate and acquired 
immunity in myocarditis. Curr Opin Cardiol. 2003;18:175-181. 
12. Kearney MT, Cotton JM, Richardson P J, Shah AM. Viral myocarditis and dilated car- 
diomyopathy: Mechanisms, manifestations, and management. Postgrad Med J. 
2001;77:4-10. 
269 
CURRENT THERAPEUTIC RESEARCH 
13. Huber SA, Lodge PA. Coxsackievirus B-3 myocarditis in Balb/c mice: Evidence for 
autoimmunity o myocyte antigens. Am JPathol. 1984;116:21-29. 
14. Jozefowski S, Biedron R, Bobek M, Marcinkiewicz J. Leukotrienes modulate cytokine 
release from dendritic ells. Immunology. 2005;116:418-428. 
15. Peters-Golden M, Canetti C, Mancuso P, Coffey MJ. Leukotrienes: Underappreciated 
mediators of innate immune responses. J Immunol. 2005; 174:589-594. 
16. Lauer B, Niederau C, Kuhl U, et al. Cardiac troponin T in patients with clinically sus- 
pected myocarditis. JAm Coil Cardiol. 1997;30:1354-1359. 
17. Yopp AC, Randolph G J, Bromberg JS. Leukotrienes, phingolipids, and leukocyte traf- 
ficking. J lmmunol. 2003;171:5-10. 
Address correspondence to: Ender Odemis, MD, Department of Pediatrics, 
Division of Pediatric Cardiology, Fatih University Faculty of Medicine, Hosdere Cad 
No. 145 Y. Ayranci, 06540 Cankaya, Ankara, Turkey. E-mail: enderodemis@gmail.com 
270 
